Skip to content
Home/Companies/Biotech/Mytos
Mytos

Mytos

Biotech·UK·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Mytos?

Mytos is currently owned by IQ Capital Partners through IQ Capital Fund IV (2022 vintage), since 2023.

Hand-verified · updated 2026-07-16

IQ Capital Partners
Investor
IQ Capital Partners
IQ Capital Fund IV · 2022 · VC

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.mytos.bio

More from IQ Capital Fund IV

Other portfolio companies in the same fund.

Imperagen
Active
BiotechUK· 2026
Isembard
Isembard
Active
Aerospace & DefenceUK· 2026
Omegga
Active
HealthTechGermany· 2026
Rivan
Active
EnergyUK· 2026
Alpine Eagle
Active
Aerospace & DefenceGermany· 2025
DaltonTx
Active
BiotechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Mytos

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Mytos.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue